The tweet was deleted by the author.
But we saved everything 🙂.
Greenwich LifeSciences has released an update on its financing strategy as it adapts to evolving market realities.
The company did not disclose specific details in the announcement. Investors are closely watching for further developments that may shed light on the potential impact of this strategy on the firm's funding and growth plans. Details are being clarified.
Earlier this year, Greenwich LifeSciences said it would provide an update on its plans for the upcoming AACR Meeting, highlighting company developments at the event (link). The firm also pursued new patent claims after reporting statistically significant immune response data from its FLAMINGO-01 study (link). These actions come as investors monitor the company’s latest financing decisions.